These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18675682)

  • 21. Comparison of insulin lispro mixture 25/75 with insulin glargine during a 24-h standardized test-meal period in patients with Type 2 diabetes.
    Roach P; Malone JK
    Diabet Med; 2006 Jul; 23(7):743-9. PubMed ID: 16842478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargine.
    Buse JB; Wolffenbuttel BH; Herman WH; Hippler S; Martin SA; Jiang HH; Shenouda SK; Fahrbach JL
    Diabetes Care; 2011 Feb; 34(2):249-55. PubMed ID: 21270182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy.
    Rosenstock J; Ahmann AJ; Colon G; Scism-Bacon J; Jiang H; Martin S
    Diabetes Care; 2008 Jan; 31(1):20-5. PubMed ID: 17934150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract]   [Full Text] [Related]  

  • 25. Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study.
    Blonde L; Jendle J; Gross J; Woo V; Jiang H; Fahrbach JL; Milicevic Z
    Lancet; 2015 May; 385(9982):2057-66. PubMed ID: 26009229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial.
    Koivisto V; Cleall S; Pontiroli AE; Giugliano D
    Diabetes Obes Metab; 2011 Dec; 13(12):1149-57. PubMed ID: 21819517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with type 2 diabetes uncontrolled by oral agents.
    Sakharova OV; Lleva RR; Dziura JD; Spollett GR; Howell SK; Beisswenger PJ; Inzucchi SE
    J Diabetes Complications; 2012; 26(4):333-8. PubMed ID: 22541894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [American Diabetes Association's Annual Meeting: new data on insulin glargine: early combination promises more success].
    MMW Fortschr Med; 2005 Aug; 147(33-34):44-5. PubMed ID: 16138636
    [No Abstract]   [Full Text] [Related]  

  • 29. [Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes].
    Fernández Landó L; Massari F; Oviedo A; Jiang H
    Medicina (B Aires); 2012; 72(3):235-42. PubMed ID: 22763161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of insulin therapy in patients with type 2 diabetes failing oral therapy: response to Mikhail and Cope and to Janka.
    Raskin P
    Diabetes Care; 2005 Nov; 28(11):2811. PubMed ID: 16249569
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial.
    Comulada AL; Renard E; Nakano M; Rais N; Mao X; Webb DM; Milicevic Z
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S17-25. PubMed ID: 19772445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.
    Mayfield JA; White RD
    Am Fam Physician; 2004 Aug; 70(3):489-500. PubMed ID: 15317436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial.
    Jia W; Xiao X; Ji Q; Ahn KJ; Chuang LM; Bao Y; Pang C; Chen L; Gao F; Tu Y; Li P; Yang J
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):254-62. PubMed ID: 25754414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.
    Bode BW; Steed RD; Schleusener DS; Strange P
    Endocr Pract; 2005; 11(3):157-64. PubMed ID: 16239201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Insulin Treatment with Glargine or Premixed Insulin Lispro Programs in Type 2 Diabetes Mellitus Patients: A Meta-analysis of Randomized Clinical Trials.
    Sun D; Zhang X; Hou XX
    Diabetes Technol Ther; 2018 Sep; 20(9):622-627. PubMed ID: 30095984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.
    Diamant M; Nauck MA; Shaginian R; Malone JK; Cleall S; Reaney M; de Vries D; Hoogwerf BJ; MacConell L; Wolffenbuttel BH;
    Diabetes Care; 2014 Oct; 37(10):2763-73. PubMed ID: 25011946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes.
    Ashwell SG; Amiel SA; Bilous RW; Dashora U; Heller SR; Hepburn DA; Shutler SD; Stephens JW; Home PD
    Diabet Med; 2006 Mar; 23(3):285-92. PubMed ID: 16492212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulation-Based Evaluation of Dose-Titration Algorithms for Rapid-Acting Insulin in Subjects with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antihyperglycemic Medications.
    Ma X; Chien JY; Johnson J; Malone J; Sinha V
    Diabetes Technol Ther; 2017 Aug; 19(8):483-490. PubMed ID: 28700249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Long-Acting Basal Insulins: Does Benefit Outweigh Cost?
    Standl E; Owen DR
    Diabetes Care; 2016 Aug; 39 Suppl 2():S172-9. PubMed ID: 27440830
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes.
    Ashwell SG; Bradley C; Stephens JW; Witthaus E; Home PD
    Diabetes Care; 2008 Jun; 31(6):1112-7. PubMed ID: 18339977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.